CHEMOMAB THERAPEUTICS
1.4800
07-November-24 14:59:58
15 minutes delayed
Stocks
+0.0500
+3.50%
Today's range
1.4500 - 1.5600
ISIN
N/A
Source
NASDAQ
-
Chemomab Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update
30 Oct 2024 06:00:00 By Nasdaq GlobeNewswire
-
15 Oct 2024 06:00:00 By Nasdaq GlobeNewswire
-
Chemomab Therapeutics to Present at October 2024 Investor Conferences
01 Oct 2024 06:00:00 By Nasdaq GlobeNewswire
-
Chemomab Therapeutics to Present at September 2024 Investor Conferences
28 Aug 2024 06:00:00 By Nasdaq GlobeNewswire
-
Chemomab Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update
21 Aug 2024 06:00:00 By Nasdaq GlobeNewswire
-
Chemomab Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update
12 Aug 2024 06:00:00 By Nasdaq GlobeNewswire
-
Chemomab Therapeutics Announces Closing of $10 Million Private Placement
30 Jul 2024 08:00:00 By Nasdaq GlobeNewswire
-
Chemomab Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
26 Jul 2024 06:00:00 By Nasdaq GlobeNewswire
-
Chemomab Therapeutics Announces $10 Million Private Placement
25 Jul 2024 06:38:21 By Nasdaq GlobeNewswire
-
18 Jun 2024 06:00:00 By Nasdaq GlobeNewswire
-
Chemomab Therapeutics to Participate in Upcoming Scientific Conferences
17 May 2024 06:00:00 By Nasdaq GlobeNewswire
-
Chemomab Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
09 May 2024 06:00:01 By Nasdaq GlobeNewswire
-
08 May 2024 06:00:00 By Nasdaq GlobeNewswire
-
Chemomab Therapeutics to Present at 2024 Aegis Virtual Conference
02 May 2024 06:00:00 By Nasdaq GlobeNewswire
-
Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update
24 Apr 2024 06:00:00 By Nasdaq GlobeNewswire
-
18 Apr 2024 06:00:00 By Nasdaq GlobeNewswire
-
02 Apr 2024 06:00:00 By Nasdaq GlobeNewswire
-
25 Mar 2024 06:06:46 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >